• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Pharmaceutical Expenditure and Burden of Non-communicable Diseases in Serbia.

作者信息

Kovacevic Aleksandra, Rancic Nemanja, Segrt Zoran, Dragojevic-Simic Viktorija

机构信息

Centre for Clinical Pharmacology, Military Medical Academy Medical Faculty, University of Defense Belgrade, Serbia.

Military Medical Academy Medical Faculty, Management of the Military Medical Academy, University of Defense Belgrade, Serbia.

出版信息

Front Pharmacol. 2016 Oct 13;7:373. doi: 10.3389/fphar.2016.00373. eCollection 2016.

DOI:10.3389/fphar.2016.00373
PMID:27790144
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5062377/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48fd/5062377/993d40da470a/fphar-07-00373-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48fd/5062377/993d40da470a/fphar-07-00373-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48fd/5062377/993d40da470a/fphar-07-00373-g0001.jpg

相似文献

1
Pharmaceutical Expenditure and Burden of Non-communicable Diseases in Serbia.塞尔维亚的药品支出与非传染性疾病负担
Front Pharmacol. 2016 Oct 13;7:373. doi: 10.3389/fphar.2016.00373. eCollection 2016.
2
Gross Domestic Product and Health Expenditure Growth in Balkan and East European Countries-Three-Decade Horizon.巴尔干和东欧国家的国内生产总值与卫生支出增长——三十年展望
Front Public Health. 2020 Sep 15;8:492. doi: 10.3389/fpubh.2020.00492. eCollection 2020.
3
Metamizole Utilization and Expenditure During 6-Year Period: Serbia vs. Croatia.六年期间美他多辛的使用情况与支出：塞尔维亚与克罗地亚对比
Front Public Health. 2018 Jul 26;6:213. doi: 10.3389/fpubh.2018.00213. eCollection 2018.
4
Tacrolimus Utilization and Expenditure in Serbia.塞尔维亚他克莫司的使用情况与支出
Front Public Health. 2017 Nov 7;5:291. doi: 10.3389/fpubh.2017.00291. eCollection 2017.
5
A Correlation Study of the Colorectal Cancer Statistics and Economic Indicators in Selected Balkan Countries.部分巴尔干国家结直肠癌统计数据与经济指标的相关性研究
Front Public Health. 2020 Feb 18;8:29. doi: 10.3389/fpubh.2020.00029. eCollection 2020.
6
Association between non-communicable disease multimorbidity and health care utilization in a middle-income country: population-based study.中低收入国家非传染性疾病共病与医疗保健利用之间的关联：基于人群的研究
Public Health. 2018 Feb;155:35-42. doi: 10.1016/j.puhe.2017.11.014. Epub 2018 Jan 4.
7
Tests of stationarity and cointegration of health care expenditure and gross domestic product: an application to Turkey.医疗保健支出与国内生产总值的平稳性和协整性检验：土耳其的应用
Eur J Health Econ. 2006 Dec;7(4):285-9. doi: 10.1007/s10198-006-0375-9.
8
Triple burden of disease and out of pocket healthcare expenditure of women in India.印度女性的疾病三重负担和医疗保健支出自付部分。
PLoS One. 2018 May 10;13(5):e0196835. doi: 10.1371/journal.pone.0196835. eCollection 2018.
9
Possible ways to enhance renin-angiotensin prescribing efficiency: Republic of Serbia as a case history?增强肾素-血管紧张素类药物处方效率的可能途径：以塞尔维亚共和国为例？
J Comp Eff Res. 2012 Nov;1(6):539-49. doi: 10.2217/cer.12.62.
10
Evolution of the Serbian pharmaceutical market alongside socioeconomic transition.塞尔维亚药品市场随社会经济转型的发展
Expert Rev Pharmacoecon Outcomes Res. 2015 Jun;15(3):521-30. doi: 10.1586/14737167.2015.1003044. Epub 2015 Jan 16.

引用本文的文献

1
Cost Analysis of Health Examination Screening Program for Ischemic Heart Disease in Active-Duty Military Personnel in the Middle-Income Country.中低收入国家现役军人缺血性心脏病健康检查筛查计划的成本分析。
Front Public Health. 2021 Mar 4;9:634778. doi: 10.3389/fpubh.2021.634778. eCollection 2021.
2
Gross Domestic Product and Health Expenditure Growth in Balkan and East European Countries-Three-Decade Horizon.巴尔干和东欧国家的国内生产总值与卫生支出增长——三十年展望
Front Public Health. 2020 Sep 15;8:492. doi: 10.3389/fpubh.2020.00492. eCollection 2020.
3
Medicine Availability and Prescribing Policy for Non-Communicable Diseases in the Western Balkan Countries.

本文引用的文献

1
Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2015: the Global Burden of Disease Study 2015.全球、区域和国家艾滋病毒发病率、流行率和死亡率估计数，1980-2015 年：2015 年全球疾病负担研究。
Lancet HIV. 2016 Aug;3(8):e361-e387. doi: 10.1016/S2352-3018(16)30087-X. Epub 2016 Jul 19.
2
Health Economics at the Crossroads of Centuries - From the Past to the Future.世纪之交的健康经济学——从过去到未来。
Front Public Health. 2016 Jun 9;4:115. doi: 10.3389/fpubh.2016.00115. eCollection 2016.
3
Comparing UK and 20 Western countries' efficiency in reducing adult (55-74) cancer and total mortality rates 1989-2010: Cause for cautious celebration? A population-based study.
西巴尔干国家非传染性疾病的药品供应与处方政策
Front Public Health. 2017 Nov 8;5:295. doi: 10.3389/fpubh.2017.00295. eCollection 2017.
4
Inpatient Treatment for the Middle-aged and Elderly in Central China.中国中部地区中老年人的住院治疗
Front Public Health. 2017 Feb 2;5:7. doi: 10.3389/fpubh.2017.00007. eCollection 2017.
比较英国与20个西方国家在1989 - 2010年期间降低成人（55 - 74岁）癌症和总死亡率方面的效率：值得谨慎庆祝吗？一项基于人群的研究。
JRSM Open. 2016 Jun 6;7(6):2054270416635036. doi: 10.1177/2054270416635036. eCollection 2016 Jun.
4
The New and Old Europe: East-West Split in Pharmaceutical Spending.新旧欧洲：制药支出的东西方分化
Front Pharmacol. 2016 Feb 9;7:18. doi: 10.3389/fphar.2016.00018. eCollection 2016.
5
Growth of Global Health Spending Share in Low and Middle Income Countries.低收入和中等收入国家全球卫生支出份额的增长情况。
Front Pharmacol. 2016 Feb 12;7:21. doi: 10.3389/fphar.2016.00021. eCollection 2016.
6
Life expectancy and health expenditure evolution in Eastern Europe-DiD and DEA analysis.东欧的预期寿命与医疗支出演变——双重差分法与数据包络分析
Expert Rev Pharmacoecon Outcomes Res. 2016 Aug;16(4):537-46. doi: 10.1586/14737167.2016.1125293. Epub 2015 Dec 17.
7
Five-year survival and costs of care in metastatic colorectal cancer: conventional versus monoclonal antibody-based treatment protocols.转移性结直肠癌的五年生存率及治疗费用：传统治疗方案与基于单克隆抗体的治疗方案对比
Expert Rev Anticancer Ther. 2015;15(8):963-70. doi: 10.1586/14737140.2015.1059280. Epub 2015 Jun 18.
8
End-of-life costs of medical care for advanced stage cancer patients.晚期癌症患者临终医疗费用。
Vojnosanit Pregl. 2015 Apr;72(4):334-41. doi: 10.2298/vsp1504334k.
9
Growing Burden of Non-Communicable Diseases in the Emerging Health Markets: The Case of BRICS.新兴健康市场中非传染性疾病负担日益加重：以金砖国家为例。
Front Public Health. 2015 Apr 23;3:65. doi: 10.3389/fpubh.2015.00065. eCollection 2015.
10
Economic Impact of Leading Prosperity Diseases: COPD in South East Europe.主要富裕型疾病的经济影响：东南欧的慢性阻塞性肺疾病
Front Public Health. 2015 Mar 24;3:50. doi: 10.3389/fpubh.2015.00050. eCollection 2015.